| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |